Challenges of systemic lupus clinical trials
Author:
Merrill Joan,Kim Mimi
Reference57 articles.
1. Connective tissue diseases: is SLE many single-organ diseases or an overlapping spectrum?;Merrill;Nat. Rev. Rheumatol.,2015
2. Brief report: longitudinal patterns of response to standard of care therapy for systemic lupus erythematosus: implications for clinical trial design;Kim;Arthritis Rheum.,2017
3. Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus;Mok;Expet Rev. Clin. Immunol.,2017
4. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial;Navarra;Lancet,2011
5. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus;Furie;Arthritis Rheum.,2011